P24 HIGH-DOSE CYCLOPHOSPHAMIDE 4 GR/M2 AND STEM-CELL COLLECTION AFTER DARATUMUMAB-BASED QUADRUPLET INDUCTION IN NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTER EXPERIENCE

• C. Liberatore,
• C. Passeri,
• F. Fioritoni,
• O. Iuliani,
• G. Montanaro,
• A. Di Nicola,
• P. Accorsi,
• S. Santarone,
• S. Pulini,
• M. Di Ianni

Affiliations

C. Liberatore

1 Clinical Hematology Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

C. Passeri

2 Blood Bank Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

F. Fioritoni

1 Clinical Hematology Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

O. Iuliani

2 Blood Bank Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

G. Montanaro

1 Clinical Hematology Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

A. Di Nicola

3 “G. D’Annunzio” University of Chieti – Pescara, Chieti, Italy

P. Accorsi

2 Blood Bank Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

S. Santarone

1 Clinical Hematology Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

S. Pulini

1 Clinical Hematology Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy

M. Di Ianni

1 Clinical Hematology Unit, Department of Oncology and Hematology, Santo Spirito Civil Hospital, Pescara, Italy